Latest News On Diabetes

Latest KFF Health News Stories

Listen: Can California Lower the Price of Insulin?

KFF Health News Original

California Healthline senior correspondent Angela Hart describes California’s ambitious plan to manufacture generic insulin under the state’s new “CalRx” drug label.

Insulin Copay Cap Passes House Hurdle, But Senate Looks for a Broader Bill

KFF Health News Original

Sens. Susan Collins (R-Maine) and Jeanne Shaheen (D-N.H.) are seeking to craft a compromise that members from both parties could accept. Their plan, still being ironed out, would not guarantee a specific limit on out-of-pocket costs but seeks to roll back insulin prices by barring rebate payments to pharmacy benefit managers.